e2730
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2017 (NCT03054194)
Timeline
Indications
Mechanism of action
- Betaine transporterINHIBITOR
SLC6A12 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- e2730
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04676685 | Phase 1 | Dec 16, 2020 | Eisai |
| NCT03603639 | Phase 2 | Jun 28, 2018 | Eisai |
| NCT03451890 | Phase 1 | Feb 9, 2018 | Eisai |
| NCT03054194 | Phase 1 | Jan 31, 2017 | Eisai |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eisai | For profit | 4 | 4 | 2 | 2017 |
1 organizations
Page 1 / 1